Zobrazeno 1 - 10
of 310
pro vyhledávání: '"L. CUSAN"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Obstetrical & Gynecological Survey. 52:427-429
We have evaluated the effect of dehydroepiandrosterone (DHEA) replacement therapy in 60- to 70-year-old women (n = 15) who received a single daily percutaneous application of a 10% DHEA cream for 12 months. While anthropometric measurements showed no
Publikováno v:
The Journal of endocrinology.
We have evaluated the effect of dehydroepiandrosterone (DHEA) replacement therapy in 60- to 70-year-old women (n = 15) who received a single daily percutaneous application of a 10% DHEA cream for 12 months. While anthropometric measurements showed no
Publikováno v:
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 6(2)
To evaluate the reliability and the validity of a French Canadian version of the International Prostatic Symptom Score.Between November 23, 1993 and April 8, 1994, a self-administered questionnaire was submitted to a group of men on two occasions at
Autor:
L, Cusan
Publikováno v:
The Canadian journal of oncology. 4
Publikováno v:
Anticancer research. 14(2B)
Suppression of androgen levels of stage D2 prostate cancer patients has been the prominent treatment for advanced prostate cancer. An arithmetic formula expressing disease aggressivity computed by the pre-treatment levels of alkaline phosphatase (AP)
Publikováno v:
Clinical and investigative medicine. Medecine clinique et experimentale. 16(6)
Combination therapy with the antiandrogen flutamide and the luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6, des-Gly-NH2(10)] LHRH ethylamide or orchiectomy was administered to 268 patients with previously untreated metastatic stage D2 p
Autor:
F, Labrie, A, Dupont, R, Suburu, L, Cusan, J L, Gomez, M, Koutsilieris, P, Diamond, J, Emond, M, Lemay, B, Candas
Publikováno v:
Clinical and investigative medicine. Medecine clinique et experimentale. 16(6)
In 1,002 men aged 45-80 y, 81% of the cancers detectable by serum prostate-specific antigen (PSA), digital rectal examination (DRE), and transrectal ultrasonography (TRUS) were present in a subpopulation (19% of total) identified by serum PSA above t